References
- Grever MR. How I treat hairy cell leukemia. Blood 2010;115:21–28.
- Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med 2011;364:2305–2315.
- Follows GA, Sims H, Bloxham DM, et al. Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib. Br J Haematol 2013;161:150–153.
- Bihl MP, Hoeller S, Andreozzi MC, et al. KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13. Diagn Mol Pathol 2012;21:14–23.
- Goodman GR, Burian C, Koziol JA, et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891–896.
- Kurzrock R, Strom SS, Estey E, et al. Second cancer risk in hairy cell leukemia: analysis of 350 patients. J Clin Oncol 1997;15:1803–1810.
- Federico M, Zinzani PL, Frassoldati A, et al. Risk of second cancer in patients with hairy cell leukemia: long-term follow-up. J Clin Oncol 2002;20:638–646.
- Cornet E, Tomowiak C, Tanguy-Schmidt A, et al. Hairy cell leukemia: evaluation of long term outcomes in 487 patients. Presented at the 18th Congress of the European Hematology Association, 13–16 June 2013, Stockholm, Sweden; S1149.
- Hisada M, Chen BE, Jaffe ES, et al. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst 2007;99:215–222.
- Setoodeh R, Zhang L. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy:report of an extremely rare case and review of the literature. Leuk Lymphoma 2012;53:736–738.
- Lawlor E, McCann SR, Whelan A, et al. Acute myeloid leukaemia occurring in untreated chronic lymphatic leukaemia. Br J Haematol 1979;43:369–373.
- Dasanu CA, Ichim T, Alexandrescu DT. Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opin Drug Saf 2010;9:55–64.
- Schnittger S, Bacher U, Haferlach T, et al. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia. Blood 2012;119: 3151–3154.
- Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011;471: 467–472.
- Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012;119:192–195.